Pesticide-Attributed Skin Symptoms in 226 Thai Agricultural Workers

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured scene is an AI-created illustration of fictional people and work or activity settings. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.

The practical question

The workers’ attribution and timing are useful surveillance signals, not proof that a pesticide caused every eruption.

Keep the paper’s population, denominator, design and timepoint attached. A workforce survey, clinic series or registry can describe patterns without diagnosing why one person’s skin changed.

Study snapshot

What the numbers can—and cannot—say

14.6% reported pesticide-attributed skin symptoms; eruptions mainly affected arms and hands and usually resolved within one to seven days after exposure stopped.

Convenience sampling limits generalizability, symptoms were self-reported, no unexposed control was enrolled and the study did not verify individual chemicals clinically.

Cross-sectional associations cannot show which came first. Registry counts depend on recognition and reporting. Patch-test positivity requires clinical relevance. A workplace comparison can reveal patterns without identifying a single causal chemical.

Build a more useful exposure history

Record the exact task, material, equipment, contact site, frequency, wet-work duration, glove type, cleanser, symptom timing, days away from exposure and functional effect. Compare workdays with days off without deliberately re-exposing skin. Photographs and a product label or safety-data list can help a clinician or occupational-health team reconstruct the sequence.

Prevention follows a hierarchy: eliminate or substitute hazards where feasible, control splashes, dusts or aerosols, improve workflow and training, then use correctly selected protective equipment. A cosmetic moisturizer can support dry-skin comfort; it cannot neutralize an allergen, corrosive chemical, contaminated water, plant resin or friction hazard.

Questions for a workplace or clinical review

• Was the study population similar to this person, or selected because symptoms were present?
• Does the body-site distribution match the suspected equipment, material, uniform or task?
• Would clinician-directed patch testing or occupational review change the plan?
• What outcome will be tracked: severity, sleep, function, absence, productivity or safe participation?
• What would trigger urgent evaluation, such as rapidly spreading redness, drainage, fever, severe pain or major functional loss?

Primary and authoritative sources

• Primary medical research record: PubMed PMID 41595890
• NIAMS: atopic dermatitis overview
• American Academy of Dermatology: skin-care guidance
• NIOSH: occupational skin-exposure recommendations

PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.

Where a cosmetic moisturizer fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and outside research does not become a product result. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.

Bottom line

The responsible conclusion is narrow: preserve the denominator, comparator, timepoint and limitations, then use the study to ask better clinical and exposure-control questions rather than to promise a universal result.

Educational content only. Researchers and cited organizations do not endorse Dr. Arsy.